Safe handling of oral chemotherapeutic agents in clinical practice: Recommendations from an international pharmacy panel

Journal of Oncology Practice

Volumn 7, Issue 1, 2011, Pages 7-12

  Goodin, By Susan ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Griffith, Niesha ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Chen, Beth ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Chuk, Karen ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Daouphars, Mikael ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Doreau, Christian ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Patel, Rinku A ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Schwartz, Rowena ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Tamés, Maria José ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Terkola, Robert ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Vadnais, Barbara ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Wright, Debbie ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Meier, Klaus ^{a,b,c,d,e,f,g,h,i,j,k,l,m}  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Biologics   (United States)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^f CENTRE HENRI BECQUEREL   (France)

^g CD Conseil   (France)

^h Diplomat Specialty Pharmacy   (United States)

ⁱ JOHNS HOPKINS HOSPITAL   (United States)

^j Pharmacy Department   (Spain)

^k KAISER FRANZ JOSEF HOSPITAL   (Austria)

^l SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^m Heidekreis Klinikum GmbH   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; CONTROLLED STUDY; DRUG INDUSTRY; DRUG MANUFACTURE; EUROPE; GOOD CLINICAL PRACTICE; HEALTH CARE PRACTICE; HUMAN; MATERIALS HANDLING; NORMAL HUMAN; NORTH AMERICA; PHARMACIST; PHARMACY; PRACTICE GUIDELINE; STANDARDIZATION;

EID: 79955696847     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2010.000068     Document Type: Article

References (45)

1. Aisner J: Overview of the changing paradigm in cancer treatment: Oral chemotherapy. Am J Health Syst Pharm 64:4-7, 2007 (suppl 5)
2. Weingart SN, Brown E, Bach PB, et al: NCCN Task Force Report: Oral chemotherapy. J Natl Compr Canc Netw 6:1-14, 2008 (suppl 3)
3. Greco FA: Evolving role of oral chemotherapy for the treatment of patients with neoplasms. Oncology (Williston Park) 12:43-50, 1998 (suppl 4) (Pubitemid 28164646)
4. Liu G, Franssen E, Fitch MI, et al: Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15:110-115, 1997 (Pubitemid 27021524)
5. Schulmeister L: Chemotherapy medication errors: Descriptions, severity, and contributing factors. Oncol Nurs Forum 26:1033-1042, 1999
6. Cohen MR, Anderson RW, Attilio RM, et al: Preventing medication errors in cancer chemotherapy. Am J Health Syst Pharm 53:737-746, 1996 (Pubitemid 26112665)
7. National Patient Safety Agency: Oral anti-cancer medicines: Risks of incorrect dosing. http://www.nrls.npsa.nhs.uk/resources/?entryid45-59880
8. Blecher C, Barefoot J, Davis D, et al: A team approach toward promoting patient adherence to oral chemotherapy protocols. Oncol Nurs Forum 35:537, 2008 (abstr 2985)
9. Ruddy K, Mayer E, Partridge A: Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 59:56-66, 2009
10. Escalada P, Griffiths P: Do people with cancer comply with oral chemotherapy treatments? Br J Community Nurs 11:532-536, 2006
11. Birner A: Pharmacology of oral chemotherapy agents. Clin J Oncol Nurs 7:11-19, 2003 (suppl 6)
12. Association paritaire pour la santéet la sécuritédu travail du secteur affaires sociales (AASTSAS): Prevention guide: Safe handling of hazardous drugs. http:// www.irsst.qc.ca/files/documents/PubIRSST/CG-002.pdf
13. Sessink PJ, Bos RP: Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs. Drug Saf 20:347-359, 1999
14. Valanis B, Vollmer W, Labuhn K, et al: Occupational exposure to antineoplastic agents and self-reported infertility among nurses and pharmacists. J Occup Environ Med 39:574-580, 1997 (Pubitemid 27280106)
15. U.S. Department of Labor, Occupational Safety and Health Administration: Controlling occupational exposure to hazardous drugs. OSHA Technical Manual, Section VI, Chapter 2. Washington, DC, 1999
16. TEVA Hospitals: Management and Awareness of Risks of Cytotoxic Handling (MARCH) guidelines: Safe handling of oral chemotherapy. http://marchguidelines. com/ members/guidelines/PNF1-OralChemotherapy.aspx
17. National Institute for Occupational Safety and Health: Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings. Atlanta, GA, NIOSH publication 2004-165, 2004
18. Grampians Integrated Cancer Service, Grampians Regional Palliative Care Team: Clinical guidelines for the administration of oral chemotherapy agents in the community setting. http://www.gics.com.au/resources/ ClinGuidelinesForOralChemoInCommunity. pdf
19. Gallagher TH, Lucas MH: Patients' and physicians' attitudes regarding disclosure of harmful medical errors, in Perry MC (ed): Am Soc Clin Oncol Ed Book, pp 254-258, 2005
20. Merseyside & Cheshire Cancer Network: Network guidance for safe prescribing, handling and administration of cytotoxic drugs. http://www.mccn.nhs.uk/userfiles/ documents/ MCCN%20Safe%20Prescribing%20handling%20%20administration%20of%20Cytotoxic%20Dru gs-April06-revDec07-oral%20August%2008-vincOct08.pdf
21. American Society of Health-Systems Pharmacists: ASHP guidelines on handling hazardous drugs. www.ashp.org/s-ashp/docs/files/BP07/Prep-Gdl-HazDrugs. pdf
22. Barbería E, Hernandez C, Miralles V, et al: Paediatric patients receiving oncology therapy: Review of the literature and oral management guidelines. Eur J Paediatr Dent 9:188-194, 2008
23. Birner A: Safe administration of oral chemotherapy. Clin J Oncol Nurs 7:158-162, 2003
24. Birner AM, Bedell MK, Avery JT, et al: Program to support safe administration of oral chemotherapy. J Oncol Pract 2:5-6, 2006
25. Canadian Association of Pharmacy in Oncology: Standards of practice for oncology pharmacy in Canada, version 2. http://www.capho.org/docs/ StandardsofPractice/ StandardsofPracticeFORWEBV2Dprintable.pdf
26. Carrington C, Stone L, Koczwara B, et al. The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy. Asia Pac J Clin Oncol 6:220-237, 2010
27. Griffin E: Safety considerations and safe handling of oral chemotherapy agents. Clin J Oncol Nurs 7:25-29, 2003 (suppl 6)
28. Jacobson JO, Polovich M, McNiff KK, et al: American Society Of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards. J Clin Oncol 27:5469-5475, 2009
29. Pratt S: The Oncology Roundtable: Oral Anticancer Agents. Implications for Patient Management and Program Economics (Practice Brief No. 31). Washington, DC, The Advisory Board Company, 2002
30. SHPA Committee of Specialty Practice in Cancer Services: SHPA standards of practice for the provision of oral chemotherapy for the treatment of cancer. J Pharm Pract Res 37:149-152, 2007
31. Viele CS: Managing oral chemotherapy: The healthcare practitioner's role. Am J Health Syst Pharm 64:S25-S32, 2007 (suppl 5) (Pubitemid 46676688)
32. Johnson PE, Chambers CR, Vaida AJ: Oncology medication safety: A 3D status report 2008. J Oncol Pharm Pract 14:169-180, 2008
33. Chan A, Leow YC, Sim MH: Patients' perspectives and safe handling of oral anticancer drugs at an Asian cancer center. J Oncol Pharm Pract 15:161-165, 2009
34. Weingart SN, Flug J, Brouillard D, et al: Oral chemotherapy safety practices at US cancer centres: Questionnaire survey. BMJ 334:407, 2007
35. Anon: Advancing the safe and appropriate use of oral chemotherapy agents. Am J Health Syst Pharm 64:36-40, 2007 (suppl 5)
36. Birner A, Rezendes M: Oral chemotherapy. Clin J Oncol Nurs 9:107-109, 2005
37. Hartigan K: Patient education: The cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs 7:21-24, 2003 (suppl 6)
38. Kiffmeyer TK, Niemöller M, Schirpenbach R, et al: [External contamination of drug packaging. Suggestions for a cleaning procedure] Krankenhauspharmazie 22:207-212, 2001 (Pubitemid 32428534)
39. Elliott RA, Marriott JL: Standardised assessment of patients' capacity to manage medications: A systematic review of published instruments. BMC Geriatr 9:27, 2009
40. Fransman W, Vermeulen R, Kromhout H: Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. Int Arch Occup Environ Health 78:403-412, 2005 (Pubitemid 40895369)
41. Wick C, Slawson MH, Jorgenson JA, et al: Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am J Health Syst Pharm 60:2314-2320, 2003 (Pubitemid 44712872)
42. Singh BN, Malhotra BK: Effects of food on the clinical pharmacokinetics of anticancer agents: Underlying mechanisms and implications for oral chemotherapy. Clin Pharmacokinet 43:1127-1156, 2004 (Pubitemid 40013180)
43. Goodin S: Oral chemotherapeutic agents: Understanding mechanisms of action and drug interactions. Am J Health Syst Pharm 64:15-24, 2007 (suppl 5)
44. Bartel SB: Safe practices and financial considerations in using oral chemotherapeutic agents. Am J Health Syst Pharm 64:8-14, 2007 (suppl 5)
45. Wong CM, Ko Y, Chan A: Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: Profiling and comparison of two drug compendia. Ann Pharmacother 42:1737-1748, 2008